annual CFF:
$7.74M-$268.71M(-97.20%)Summary
- As of today (July 4, 2025), BEAM annual cash flow from financing activities is $7.74 million, with the most recent change of -$268.71 million (-97.20%) on December 31, 2024.
- During the last 3 years, BEAM annual CFF has fallen by -$748.40 million (-98.98%).
- BEAM annual CFF is now -98.98% below its all-time high of $756.14 million, reached on December 31, 2021.
Performance
BEAM Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$473.38M+$469.94M(+13645.03%)Summary
- As of today (July 4, 2025), BEAM quarterly cash flow from financing activities is $473.38 million, with the most recent change of +$469.94 million (+13645.03%) on March 31, 2025.
- Over the past year, BEAM quarterly CFF has increased by +$470.48 million (+16240.32%).
- BEAM quarterly CFF is now at all-time high.
Performance
BEAM quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$478.22M+$470.48M(+6081.72%)Summary
- As of today (July 4, 2025), BEAM TTM cash flow from financing activities is $478.22 million, with the most recent change of +$470.48 million (+6081.72%) on March 31, 2025.
- Over the past year, BEAM TTM CFF has increased by +$297.29 million (+164.31%).
- BEAM TTM CFF is now -44.69% below its all-time high of $864.59 million, reached on September 30, 2021.
Performance
BEAM TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
BEAM Cash from financing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -97.2% | +10000.0% | +164.3% |
3 y3 years | -99.0% | +750.2% | -14.4% |
5 y5 years | -81.3% | +145.3% | +144.5% |
BEAM Cash from financing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -99.0% | at low | at high | >+9999.0% | at high | +6081.7% |
5 y | 5-year | -99.0% | at low | at high | >+9999.0% | -44.7% | +6081.7% |
alltime | all time | -99.0% | at low | at high | >+9999.0% | -44.7% | +6081.7% |
BEAM Cash from financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $473.38M(>+9900.0%) | $478.22M(+6081.7%) |
Dec 2024 | $7.74M(-97.2%) | $3.44M(+172.9%) | $7.74M(-79.6%) |
Sep 2024 | - | $1.26M(+848.9%) | $38.01M(-48.3%) |
Jun 2024 | - | $133.00K(-95.4%) | $73.52M(-59.4%) |
Mar 2024 | - | $2.90M(-91.4%) | $180.93M(-34.6%) |
Dec 2023 | $276.45M(+147.7%) | $33.71M(-8.3%) | $276.45M(+0.6%) |
Sep 2023 | - | $36.78M(-65.8%) | $274.75M(+14.7%) |
Jun 2023 | - | $107.54M(+9.3%) | $239.53M(+55.2%) |
Mar 2023 | - | $98.42M(+207.4%) | $154.33M(+38.3%) |
Dec 2022 | $111.59M(-85.2%) | $32.01M(+1949.4%) | $111.59M(+10.4%) |
Sep 2022 | - | $1.56M(-93.0%) | $101.12M(-75.9%) |
Jun 2022 | - | $22.34M(-59.9%) | $420.44M(-24.7%) |
Mar 2022 | - | $55.68M(+158.4%) | $558.54M(-26.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | $756.14M(+134.6%) | $21.54M(-93.3%) | $756.14M(-12.5%) |
Sep 2021 | - | $320.89M(+100.0%) | $864.59M(+59.0%) |
Jun 2021 | - | $160.44M(-36.7%) | $543.80M(+42.1%) |
Mar 2021 | - | $253.27M(+94.8%) | $382.58M(+18.7%) |
Dec 2020 | $322.32M(+680.8%) | $129.99M(>+9900.0%) | $322.32M(+67.0%) |
Sep 2020 | - | $94.00K(-112.1%) | $193.03M(-1.3%) |
Jun 2020 | - | -$779.00K(-100.4%) | $195.63M(-0.4%) |
Mar 2020 | - | $193.01M(>+9900.0%) | $196.38M(+375.8%) |
Dec 2019 | $41.28M(-77.0%) | $699.00K(-74.0%) | $41.28M(+1.7%) |
Sep 2019 | - | $2.69M(<-9900.0%) | $40.58M(+7.1%) |
Jun 2019 | - | -$20.00K(-100.1%) | $37.89M(-0.1%) |
Mar 2019 | - | $37.91M | $37.91M |
Dec 2018 | $179.73M | - | - |
FAQ
- What is Beam Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Beam Therapeutics?
- What is Beam Therapeutics annual CFF year-on-year change?
- What is Beam Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Beam Therapeutics?
- What is Beam Therapeutics quarterly CFF year-on-year change?
- What is Beam Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Beam Therapeutics?
- What is Beam Therapeutics TTM CFF year-on-year change?
What is Beam Therapeutics annual cash flow from financing activities?
The current annual CFF of BEAM is $7.74M
What is the all time high annual CFF for Beam Therapeutics?
Beam Therapeutics all-time high annual cash flow from financing activities is $756.14M
What is Beam Therapeutics annual CFF year-on-year change?
Over the past year, BEAM annual cash flow from financing activities has changed by -$268.71M (-97.20%)
What is Beam Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of BEAM is $473.38M
What is the all time high quarterly CFF for Beam Therapeutics?
Beam Therapeutics all-time high quarterly cash flow from financing activities is $473.38M
What is Beam Therapeutics quarterly CFF year-on-year change?
Over the past year, BEAM quarterly cash flow from financing activities has changed by +$470.48M (+16240.32%)
What is Beam Therapeutics TTM cash flow from financing activities?
The current TTM CFF of BEAM is $478.22M
What is the all time high TTM CFF for Beam Therapeutics?
Beam Therapeutics all-time high TTM cash flow from financing activities is $864.59M
What is Beam Therapeutics TTM CFF year-on-year change?
Over the past year, BEAM TTM cash flow from financing activities has changed by +$297.29M (+164.31%)